Product category:
Clinical chemistry analysis
News Release from: Perkin Elmer LAS (UK)
Edited by the Laboratorytalk Editorial
Team on 21 January 2003
New subsidiary in China for PerkinElmer
PerkinElmer has announced that it has established a new subsidiary in the Shanghai WaiGaoQiao Free Trade Zone in China
PerkinElmer has announced that it has established a new subsidiary in the Shanghai WaiGaoQiao Free Trade Zone in China, paving the way for further expansion of its Life and Analytical Sciences' organization to better serve customers The establishment of this new legal entity, effective this month, enables PerkinElmer's Life and Analytical Sciences' business to extend its presence in China and in the Asia-Pacific region, and set its sights on achieving a goal of doubling its China business over the next five years
This article was originally published on Laboratorytalk on 19 Apr 2002 at 8.00am (UK)
Related stories
Probing the source of diabetes
Newly developed gene probes increase efficiency and speed of research in studies of type 1 (juvenile) diabetes, detecting the presence of alleles by hybridisation reaction
Manage the entire gene expression process
With microarray labs generating more than one million primary data points daily, this gene expression data management software could speed up actual gene and drug discovery
The new Life and Analytical Sciences China subsidiary will consist of approximately 100 sales and service employees.
"Our strategic decision to expand our base of operations in China underscores our long-term commitment to better serve our current and future customers in this region," said Peter Coggins, Ph.D., president of PerkinElmer Life and Analytical Sciences.
"This concentration of resources closer to customers will put us in a much better position to fully understand their most pressing business challenges, enabling us to more quickly respond to their requirements for biopharmaceutical, environmental, chemical, and genetic screening solutions that best solve their application needs, and help provide them a competitive advantage." The company's Life and Analytical Sciences' business currently staffs six representative offices across China, serving customers in the biopharmaceutical, environmental, chemical, and genetic screening industries.
PerkinElmer's Optoelectronics business unit has operated in China for more than 15 years, and currently has approximately 1,200 employees in this region.
PerkinElmer views China as a significant growth market based on the country's projected annual GDP growth rate of seven percent and its multibillion-dollar investment in an educational, environmental, pharmaceutical, and biotechnology infrastructure, including its plans to invest $100 million to expand and upgrade the research and analytical capabilities of its top 100 universities, and its $85 billion commitment to clean air and water initiatives.
PerkinElmer is also targeting China, one of the world's fastest growing markets for genetic screening, for further expansion of the company's genetic screening business.
(This was Laboratorytalk's Top Story on 18 January 2003).
• Perkin Elmer LAS (UK): contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
